The in vitro activities of the new spectinomycin analog U-63366 and four new quinolone derivatives, rosoxacin, norfloxacin, ofloxacin, and ciprofloxacin, were compared with those of penicillin, tetracycline, thiamphenicol, cefotaxime, ceftriaxone, and spectinomycin against 222 beta-lactamase-negative and 25 betalactamase-positive Neisseria gonorrhoeae strains. U-63366 was more active than spectinomycin, inhibiting 90% of the strains at a concentration of 2 mg/liter. Among the quinolone derivatives, ciprofloxacin was the most active compound in vitro (90% MIC, 0.002 mg/liter), followed by ofloxacin (90% MIC, 0.008 mg/liter), norfloxacin (90% MIC, 0.015 mg/liter), and rosoxacin (90% MIC, 0.03 mg/liter).
The emergence of penicillinase-producing isolates of Neisseria gonorrhoeae (PPNGs) and the high MIC of tetracycline among these strains have stimulated the search for alternative antimicrobial agents that are effective against infections with PPNGs as well as with gonococcal strains with reduced susceptibility to penicillin. Spectinomycin has been widely used for the treatment of PPNG infections, and spectinomycin-resistant PPNG strains are still rare (1) . Until now, mainly second-and third-generation cephalosporins have been actively investigated as alternative drugs for PPNG infections, and they already are widely used in some countries. However, cefuroxime-resistant N. gonorrhoeae strains have been reported in the Netherlands (6), and isolates resistant to the newer cephalosporins may rapidly emerge (11) .
We report here on the activity of U-63366, a new spectinomycin analog, and four new quinolone derivatives against penicillinase-negative N. gonorrhoeae isolates and PPNGs.
The These results agree with recently published in vitro susceptibilities (7, 9, 12) .
Although the MIC50 and MIC90 of the quinolones for the PPNGs were one to three dilutions higher than those for the penicillinase-negative isolates, the overall range of MICs of the four compounds was almost identical for both groups of strains. The slightly higher MICs for the PPNGs may be due to an overall lower susceptibility of these isolates, which were all acquired outside Belgium. PPNGs also exhibited slightly higher median MICs of ceftriaxone and U-63366 but not of cefotaxime and spectinomycin. In contrast, tetracycline and thiamphenicol were much less active against PPNGs, with an eightfold increase in the median MIC of both antibiotics. Thus, more than 50% of the PPNGs had MICs of tetracycline and thiamphenicol of .2 mg and .1 mg, respectively, per liter.
The in vitro results suggest that the newer quinolones may be effective drugs for the treatment of gonococcal infection. The peak serum and inflammatory tissue levels of norfloxacin and ciprofloxacin are much in excess of the observed MICs of the compounds for N. gonorrhoeae (2, 5) . Rosoxa- cin has been shown to be effective for the treatment of gonorrhea, due to both penicillinase-negative strains and PPNGs (1, 4, 7, 8) . However, central nervous system side effects of a 200-mg single dose were found in up to 59% of patients, and in one trial with infections with PPNGs, a failure rate of 17% was observed (4, 7, 8) .
On the basis of their in vitro susceptibility and of pharma- 
